vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and AMREP CORP. (AXR). Click either name above to swap in a different company.

ASP Isotopes Inc. is the larger business by last-quarter revenue ($16.7M vs $14.6M, roughly 1.1× AMREP CORP.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs 93.8%). AMREP CORP. produced more free cash flow last quarter ($5.4M vs $-47.4M).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

AMREP Corporation is a real estate and media services company based in Princeton, New Jersey, in the United States. It was founded in 1961 as The American Realty and Petroleum Corporation.

ASPI vs AXR — Head-to-Head

Bigger by revenue
ASPI
ASPI
1.1× larger
ASPI
$16.7M
$14.6M
AXR
Growing faster (revenue YoY)
ASPI
ASPI
+1201.9% gap
ASPI
1295.7%
93.8%
AXR
More free cash flow
AXR
AXR
$52.8M more FCF
AXR
$5.4M
$-47.4M
ASPI

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ASPI
ASPI
AXR
AXR
Revenue
$16.7M
$14.6M
Net Profit
$3.1M
Gross Margin
12.5%
Operating Margin
20.6%
Net Margin
21.6%
Revenue YoY
1295.7%
93.8%
Net Profit YoY
-586.8%
338.9%
EPS (diluted)
$0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
AXR
AXR
Q1 26
$14.6M
Q4 25
$16.7M
$9.4M
Q3 25
$4.9M
$17.9M
Q2 25
$11.2M
Q1 25
$7.5M
Q4 24
$11.9M
Q3 24
$19.1M
Q2 24
$19.5M
Net Profit
ASPI
ASPI
AXR
AXR
Q1 26
$3.1M
Q4 25
$1.2M
Q3 25
$-12.9M
$4.7M
Q2 25
$3.9M
Q1 25
$717.0K
Q4 24
$4.0M
Q3 24
$4.1M
Q2 24
$4.1M
Gross Margin
ASPI
ASPI
AXR
AXR
Q1 26
Q4 25
12.5%
Q3 25
8.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
ASPI
ASPI
AXR
AXR
Q1 26
20.6%
Q4 25
11.9%
Q3 25
-306.1%
34.4%
Q2 25
31.7%
Q1 25
5.7%
Q4 24
26.4%
Q3 24
26.1%
Q2 24
23.9%
Net Margin
ASPI
ASPI
AXR
AXR
Q1 26
21.6%
Q4 25
12.8%
Q3 25
-263.7%
26.3%
Q2 25
34.8%
Q1 25
9.5%
Q4 24
33.9%
Q3 24
21.3%
Q2 24
21.2%
EPS (diluted)
ASPI
ASPI
AXR
AXR
Q1 26
$0.58
Q4 25
$0.22
Q3 25
$-0.15
$0.87
Q2 25
$0.73
Q1 25
$0.13
Q4 24
$0.75
Q3 24
$0.76
Q2 24
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
AXR
AXR
Cash + ST InvestmentsLiquidity on hand
$333.3M
$50.0M
Total DebtLower is stronger
$14.4M
$21.0K
Stockholders' EquityBook value
$204.2M
$139.4M
Total Assets
$498.0M
$143.9M
Debt / EquityLower = less leverage
0.07×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
AXR
AXR
Q1 26
$50.0M
Q4 25
$333.3M
$44.6M
Q3 25
$113.9M
$48.9M
Q2 25
$39.5M
Q1 25
$36.9M
Q4 24
$40.1M
Q3 24
$40.4M
Q2 24
$29.7M
Total Debt
ASPI
ASPI
AXR
AXR
Q1 26
$21.0K
Q4 25
$14.4M
$23.0K
Q3 25
$13.9M
$25.0K
Q2 25
$26.0K
Q1 25
$29.0K
Q4 24
$32.0K
Q3 24
$34.0K
Q2 24
$35.0K
Stockholders' Equity
ASPI
ASPI
AXR
AXR
Q1 26
$139.4M
Q4 25
$204.2M
$136.0M
Q3 25
$74.1M
$134.7M
Q2 25
$130.0M
Q1 25
$126.0M
Q4 24
$125.1M
Q3 24
$122.2M
Q2 24
$118.0M
Total Assets
ASPI
ASPI
AXR
AXR
Q1 26
$143.9M
Q4 25
$498.0M
$140.1M
Q3 25
$225.9M
$140.7M
Q2 25
$133.8M
Q1 25
$128.9M
Q4 24
$129.1M
Q3 24
$127.0M
Q2 24
$122.8M
Debt / Equity
ASPI
ASPI
AXR
AXR
Q1 26
0.00×
Q4 25
0.07×
0.00×
Q3 25
0.19×
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
AXR
AXR
Operating Cash FlowLast quarter
$-37.8M
$5.4M
Free Cash FlowOCF − Capex
$-47.4M
$5.4M
FCF MarginFCF / Revenue
-284.7%
37.0%
Capex IntensityCapex / Revenue
57.9%
0.1%
Cash ConversionOCF / Net Profit
1.72×
TTM Free Cash FlowTrailing 4 quarters
$20.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
AXR
AXR
Q1 26
$5.4M
Q4 25
$-37.8M
$-4.3M
Q3 25
$-8.9M
$9.5M
Q2 25
$10.2M
Q1 25
$-3.2M
Q4 24
$-182.0K
Q3 24
$10.7M
Q2 24
$10.7M
Free Cash Flow
ASPI
ASPI
AXR
AXR
Q1 26
$5.4M
Q4 25
$-47.4M
$-4.3M
Q3 25
$-12.0M
$9.5M
Q2 25
$9.7M
Q1 25
$-3.3M
Q4 24
$-268.0K
Q3 24
$10.7M
Q2 24
$10.3M
FCF Margin
ASPI
ASPI
AXR
AXR
Q1 26
37.0%
Q4 25
-284.7%
-45.9%
Q3 25
-245.5%
53.2%
Q2 25
86.4%
Q1 25
-43.4%
Q4 24
-2.3%
Q3 24
55.8%
Q2 24
52.5%
Capex Intensity
ASPI
ASPI
AXR
AXR
Q1 26
0.1%
Q4 25
57.9%
0.6%
Q3 25
64.4%
0.1%
Q2 25
5.2%
Q1 25
0.3%
Q4 24
0.7%
Q3 24
0.2%
Q2 24
2.3%
Cash Conversion
ASPI
ASPI
AXR
AXR
Q1 26
1.72×
Q4 25
-3.54×
Q3 25
2.03×
Q2 25
2.63×
Q1 25
-4.51×
Q4 24
-0.05×
Q3 24
2.63×
Q2 24
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons